Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Close Concerns

www.closeconcerns.com

Close Concerns provides consulting services on diabetes to a wide range of established and start-up corporate clients, including pharmaceutical, medical device, and biotechnology companies. Close Concerns also publishes Diabetes Close Up, a monthly newsletter focused on clinical and commercial developments in the field, and produces special reports on products and trends influencing diabetes. They attend 30+ medical conferences and meetings per year globally that focus on diabetes and obesity. Close Concerns also has strong relationships with many of the leading researchers and clinicians in diabetes.

Leading Experts at Close Concerns(?)

Total Experts: 2
Kelly Close, President, Close ConcernsKelly Close
President

Kelly Close is Founder and President of Close Concerns, a healthcare information firm focused exclusively on diabetes and obesity. She has over 15 years of experience at the intersection of finance and healthcare. Ms. Close specializes in financial analysis and marketing within the diabetes and obesity...

Mark Yarchoan
Consultant

Mark Yarchoan joined Close Concerns in June, 2007 after graduating from Amherst College with a degree in neuroscience. He is interested in health policy and medicine, and he pursued these interests throughout his undergraduate studies. In 2005, Mark received the Hotchkiss/Patrick Fellowship to fund...

View All Leading Experts at Close Concerns

GLG NewsSMAnalyses by Leading Experts at Close Concerns(?)

Top 5 Recent News
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
byetta / LAR will be multi-billion dollar drug | 08-08-2008
Author: Kelly Close, President, Close Concerns

This was a great NYT story.  The fact that Byetta was suggested as cardioprotective out of ACCORD was truly ignored by the media and nice to see the suggestion here. FDA is moving much more this direction and from a patient perspective, having a cardioprotective drug (LAR) that is easier to take than insulin (no hypo, no weight gain, 2% A1c drop) will be shown to be revolutionary. 

Galvus spells hassle | 02-07-2008
Author: Kelly Close, President, Close Concerns

Galvus was not approved in a once per day 100 mg version for Europe, which puts it as a disadvantage to Merck's Januvia. To boot, there are liver testing requirements that will also be a drag. 

View All GLG News Analyses by Leading Experts at Close Concerns

Events Hosted by Leading Experts at Close Concerns(?)

Total Events: 0
Leading Experts at Close Concerns are not hosting any Events
View All GLG Seminars in Healthcare

Request a consultation with Close Concerns








Analytics